Post by Vertex Pharmaceuticals on X
Vertex Pharmaceuticals@VertexPharma
XToday the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the label expansion of our fourth cystic fibrosis (CF) medicine to include an expanded population with certain mutations. This marks an important step
31 likes4 repliesPosted Feb 28, 2025